Adenosine Receptors in Neurodegenerative Diseases

Produk Detail:
  • Author : David Blum
  • Publisher : Academic Press
  • Pages : 280 pages
  • ISBN : 0128037458
  • Rating : /5 from reviews
CLICK HERE TO GET THIS BOOK >>>Adenosine Receptors in Neurodegenerative Diseases

Download or Read online Adenosine Receptors in Neurodegenerative Diseases full in PDF, ePub and kindle. this book written by David Blum and published by Academic Press which was released on 10 March 2017 with total page 280 pages. We cannot guarantee that Adenosine Receptors in Neurodegenerative Diseases book is available in the library, click Get Book button and read full online book in your kindle, tablet, IPAD, PC or mobile whenever and wherever You Like. Adenosine Receptors in Neurodegenerative Diseases covers the role of adenosine receptors in brain function, also focusing on related methodologies and perspectives in therapeutics. The book provides an up-to-date overview by the best specialists in the field, helping readers consider the importance of adenosine and expand the global impact and visibility of adenosine research in the CNS field. Chapters include adenosine biology and signaling, gene regulation, control of motor function, and novel adenosine-based therapies in the CNS. It is an ideal resource for researchers, advanced graduate students, clinicians, and industry scientists working in the fields of clinical neuroscience and molecular and cellular neuroscience. Comprehensive reference that details adenosine receptors in neurodegenerative disorders, with details on brain function and possible therapeutics Gives insights on how these receptors modulate the neurodegenerative outcomes in different disorders Edited by two of the leading researchers in the field regarding adenosine role in the brain in aging and neurodegenerative conditions

Adenosine Receptors in Neurodegenerative Diseases

Adenosine Receptors in Neurodegenerative Diseases
  • Author : David Blum,Luisa V. Lopes
  • Publisher : Academic Press
  • Release : 10 March 2017
GET THIS BOOK Adenosine Receptors in Neurodegenerative Diseases

Adenosine Receptors in Neurodegenerative Diseases covers the role of adenosine receptors in brain function, also focusing on related methodologies and perspectives in therapeutics. The book provides an up-to-date overview by the best specialists in the field, helping readers consider the importance of adenosine and expand the global impact and visibility of adenosine research in the CNS field. Chapters include adenosine biology and signaling, gene regulation, control of motor function, and novel adenosine-based therapies in the CNS. It is an ideal

Adenosine

Adenosine
  • Author : Susan Masino,Detlev Boison
  • Publisher : Springer Science & Business Media
  • Release : 30 August 2012
GET THIS BOOK Adenosine

Homeostasis of key metabolites and metabolic health affects all bodily systems. Not surprisingly, altered metabolic function is associated with a wide spectrum of dysfunctions in the central nervous system – including developmental disorders, acute nervous system injury, and neurodegenerative disorders. Accordingly, metabolism-based therapies offer significant promise as new category of treatment options designed to limit, delay or reverse the disease process by reconstructing homeostatic functions. Increasingly it is appreciated that restoring metabolic health could promote normal nervous system activity, and improve

Adenosine Receptors

Adenosine Receptors
  • Author : Gyorgy Hasko,Bruce N. Cronstein,Csaba Szabo
  • Publisher : CRC Press
  • Release : 20 July 2006
GET THIS BOOK Adenosine Receptors

After a century of research, several lines of evidence now indicate that the ability of adenosine to directly control inflammatory cells has a major impact on the functions of the inflammatory and immune systems. Consequently, many promising therapeutic approaches are beginning to emerge that focus on the modulation of adenosine, including the development of compounds that interfere with the breakdown of adenosine, as well as specific agonists and antagonists of various adenosine subtypes. Some of these compounds have already entered

Parkinson s Disease in Focus

Parkinson s Disease in Focus
  • Author : Charles Tugwell
  • Publisher : Unknown
  • Release : 18 June 2021
GET THIS BOOK Parkinson s Disease in Focus

This is a concise guide to Parkinson's Disease.As with all other titles in the "In Focus" series, "Parkinson's Disease in Focus" discusses the signs, symptoms, diagnosis of the disease and the management, monitoring, treatment and care of patients.This text enables readers to improve the quality of care provided to patients suffering with Parkinson's Disease by increasing their knowledge and understanding of the clinical management of this condition. The book provides a framework for good practice with particular focus

Caffeine Adenosine Receptors and Estrogen in Toxin Models of Parkinson s Disease

Caffeine  Adenosine Receptors and Estrogen in Toxin Models of Parkinson s Disease
  • Author : Anonim
  • Publisher : Unknown
  • Release : 18 June 2021
GET THIS BOOK Caffeine Adenosine Receptors and Estrogen in Toxin Models of Parkinson s Disease

Continued progress has been made toward each of the Specific Aims (SAs) 1 and 2 (SA 3 completed) of our research project, Caffeine, adenosine receptors and estrogen in toxin models of Parkinson's disease (PD) . The overarching hypothesis of the project is that multiple environmental protectants and toxins interact to influence of the health of the dopaminergic neurons lost in PD. To that end we are characterizing the interplay between several environmental agents (pesticides, caffeine and estrogen) that are leading candidate modulators of PD

Comprehensive medicinal chemistry II

Comprehensive medicinal chemistry II
  • Author : John B. Taylor,D. J. Triggle
  • Publisher : Elsevier Science Ltd
  • Release : 18 June 2021
GET THIS BOOK Comprehensive medicinal chemistry II

The first edition of Comprehensive Medicinal Chemistry was published in 1990 and very well received. Comprehensive Medicinal Chemistry II is much more than a simple updating of the contents of the first edition. Completely revised and expanded, this new edition has been refocused to reflect the significant developments and changes over the past decade in genomics, proteomics, bioinformatics, combinatorial chemistry, high-throughput screening and pharmacology, and more. The content comprises the most up-to-date, authoritative and comprehensive reference text on contemporary medicinal chemistry

Neuroprotective Roles of the P2Y2 Nucleotide Receptor

Neuroprotective Roles of the P2Y2 Nucleotide Receptor
  • Author : Christina N. Thebeau
  • Publisher : Unknown
  • Release : 18 June 2021
GET THIS BOOK Neuroprotective Roles of the P2Y2 Nucleotide Receptor

Purinergic signaling plays a unique role in the brain by integrating neuronal and glial cellular circuits. The metabotropic P1 adenosine receptors and P2Y nucleotide receptors and ionotropic P2X receptors control numerous physiological functions of neuronal and glial cells and have been implicated in a wide variety of neuropathologies. Emerging research suggests that purinergic receptor interactions between cells of the central nervous system (CNS) have relevance in the prevention and attenuation of neurodegenerative diseases resulting from chronic inflammation. CNS

Neuroprotection

Neuroprotection
  • Author : Raymond Chuen-Chung Chang,Yuen-Shan Ho
  • Publisher : BoD – Books on Demand
  • Release : 28 August 2019
GET THIS BOOK Neuroprotection

Neuroprotection is a strategy to prevent or delay the progression of chronic neurodegenerative diseases, acute neurological disorders, or even mental disorders. The major aim of this book is to focus on different approaches to achieve neuroprotection. In this book, there are chapters discussing imidazoline ligands and opioid ligands in Alzheimer's disease, the beneficial effects of adenosine A2A receptor antagonist, adrenergic receptor agonists and antagonists modulating microglial responses, and different approaches to achieve neuroprotection against aging-associated macular degeneration. This book

Neuroinflammation Induces Time dependant Behavioral Cellular and Molecular Changes that Resemble Characteristics of Alzheimer s and Parkinson s Diseases and Can be Modulated by Caffeine Administration

Neuroinflammation Induces Time dependant Behavioral  Cellular and Molecular Changes that Resemble Characteristics of Alzheimer s and Parkinson s Diseases and Can be Modulated by Caffeine Administration
  • Author : Holly Marie Brothers
  • Publisher : Unknown
  • Release : 18 June 2021
GET THIS BOOK Neuroinflammation Induces Time dependant Behavioral Cellular and Molecular Changes that Resemble Characteristics of Alzheimer s and Parkinson s Diseases and Can be Modulated by Caffeine Administration

Abstract: Chronic neuroinflammation is a common characteristic of neurodegenerative diseases, such as Alzheimer's and Parkinson's diseases, that may contribute to loss of function and cell death. Cell loss in the hippocampus and cortex is characteristic of Alzheimer's disease (AD), Parkinson's disease (PD) is marked by the loss of cells in the substantia nigra (SN), and both the locus coeruleus (LC) and the raphe nucleus are known to be affected in these diseases. Caffeine, an adenosine antagonist, is protective against the